Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States
Abstract Background Prevalence of hemolytic neonatal hyperbilirubinemia (NHB) is not well characterized, and economic burden at the population level is poorly understood. This study evaluated the prevalence, clinical characteristics, and economic burden of hemolytic NHB newborns receiving treatment...
Saved in:
Main Authors: | Tzy-Chyi Yu (Author), Chi Nguyen (Author), Nancy Ruiz (Author), Siting Zhou (Author), Xian Zhang (Author), Elaine A. Böing (Author), Hiangkiat Tan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Failure and Hyperbilirubinemia Secondary to Hemolytic Disease of the Newborn
by: Matthew Reinhardt, et al.
Published: (2024) -
The Neurodevelopmental Outcome of Severe Neonatal Hemolytic and Nonhemolytic Hyperbilirubinemia
by: Rüya Çolak, et al.
Published: (2020) -
The Neurodevelopmental Outcome of Severe Neonatal Haemolytic and Non-hemolytic Hyperbilirubinemia
by: Amar Taksande
Published: (2021) -
Clofibrate in the Treatment of the Non-hemolytic Hyperbilirubinemia in Preterm Neonates in Western Iran
by: fatemeh eghbalian, et al.
Published: (2021) -
Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease
by: Daniel R. Mohan, et al.
Published: (2023)